Informa Australia is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Healthcare | Technology

Stephen Munn on healthcare technology assessment

3 Oct 2014, by Informa Insights

In the lead up to the 3rd Annual Health Technology Assessment Conference, Professor Stephen Munn, Clinical Director, Transplantation at Auckland District Health Board joined us to talk about healthcare technology assessment.

My expertise in HTA comes from 9 years as the chair of a hospital-based HTA unit during which time we’ve received more than 75 submissions from a broad range of departments.

We’ve used an in-house scoring tool to help us compare dissimilar technologies and thereby provide robust advice to the hospital. Such advice has been, for the most part, accepted and acted upon. Recent examples of submissions include; alcohol caps to prevent central line associated blood stream infections, the use of FEIBA to reverse dabigatran  induced coagulopathy, intra-operative radiation treatment for breat cancer, and cryoablation for atrial fibrillation.

I believe hospital-based HTA has an advantage over more remote analyses because it allows detailed pathway comparison that includes current and projected costs. Furthermore, it can consider local training and logistic issues that might not exist in other institutions.

Regulation is a barrier to some innovation – hopefully only the unsafe, less well proven, ineffective or eye-wateringly expensive forms of innovation!

Global HTA can help enormously with the academic part of HTA and it might prevent a lot of duplication. However, it cannot help with the detailed application of that HTA to the local circumstances, especially when there are competing technologies and a limited purse.

I will be speaking at the upcoming Health Technology Assessment Conference, taking place on 24th and 25th November in Sydney, on the topic “Hospital-based HTA: The Missing Link between Analysis and Decision-Making”.  I’m looking forward to learning about novel health technologies and to hearing about industry attitude to comparative clinical studies.

Join Professor Munn at the event.


Blog insights you may like

Get all the latest on Informa news and events

Informa Connect Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more

Subscribe to Insights

Join Our Newsletter
Informa Insights

Stay up-to-date with all the latest
updates, upcoming events & more.